Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alex azar
2
×
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicaid
2
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
trump administration
wisconsin blog main
wisconsin top stories
aducanumab
affordable care act
aldeyra therapeutics
alliance for aging research
alzheimer's disease
amgen
bayer
biotechnology innovation organization
brammer bio
bristol-myers squibb
What
drug
2
×
administration
aducanumab
alzheimer’s
amyloid
angry
angst
anti
bagged
benefited
billions
bio
biogen
biogen’s
brammer
despite
effects
failure
fear
felt
industry
losing
lost
nash
news
pharma
plans
presidential
price
rhetoric
ripple
roundup
rx
scalps
split
thanks
trump
tweets
week
Language
Current search:
medicaid
×
drug
×
" alex azar "
×
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
